Literature DB >> 18342013

Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Arijit Biswas1, Jyoti Bajaj, Ravi Ranjan, Arvind Meena, Mohd Suhail Akhter, Birendra Kumar Yadav, Vinita Sharma, Renu Saxena.   

Abstract

BACKGROUND: Deep vein thrombosis is a condition, which has several acquired as well as genetic causes. One of the most common reasons for deep vein thrombosis is activated protein C resistance caused by Factor V Leiden.
METHOD: We examined the risk posed by Factor V Leiden, Hong Kong/Cambridge and HR2 Haplotype mutations in 155 deep vein thrombosis patients and 120 healthy controls in the background of activated protein C resistance. RESULT: Thirty-one of our patients showed activated protein C resistance of which only 16 carried Factor V Leiden mutation which was a far lower number than what is usually seen in Caucasian population. Factor V Leiden mutation was significantly associated with the risk of deep vein thrombosis (Yates corrected p-value=0.002; 95%CI; odds ratio: 13.7). Factor V Hong Kong/Cambridge and HR2 Haplotype were not found to be associated with the risk of deep vein thrombosis. There is a possibility that Factor V HR2 Haplotype might also be associated with activated protein C resistance even in the absence of Factor V Leiden.
CONCLUSIONS: Factor V Leiden mutation was seen to contribute far less towards activated protein C resistance in Asian-Indian deep vein thrombosis patients than what has been commonly observed in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342013     DOI: 10.1016/j.cca.2008.02.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.

Authors:  Amit Sharma; Teena Bhakuni; Ravi Ranjan; Ravi Kumar; Kamal Kishor; Vineet Kumar Kamal; Manoranjan Mahapatra; Mohamad Aman Jairajpuri; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

2.  Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.

Authors:  Amit Sharma; Kanwaljeet Singh; Arijit Biswas; Ravi Ranjan; Kamal Kishor; Ravi Kumar; Hareram Pandey; Vineet Kumar Kamal; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

3.  Deep vein thrombosis: related to anemophilous pollen?

Authors:  Bin Zhou; Yiqing Li; Dan Shang; Yiping Dang; Weici Wang; Shi Sheng; Xianghai Kong; Bi Jin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

Review 4.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

5.  Effect of Platelet Glycoprotein IIb/IIIa PLA2 Polymorphism on Severity of Pulmonary Thromboembolism.

Authors:  Hamid Rouhi Boroujeni; Batoul Pourgheysari; Alimohammad Hasheminia; Parnia Rouhi Boroujeni; Fatima Drees
Journal:  Tanaffos       Date:  2014

6.  Association of Homozygous Thrombophilia Polymorphisms and Venous Thromboembolism in Shahrekord, Iran.

Authors:  Hamid Rouhi-Broujeni; Batoul Pourgheysari; Ali-Mohammad Hasheminia
Journal:  Tanaffos       Date:  2016

7.  Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population.

Authors:  Eray Yıldız; Funda Müşerref Türkmen
Journal:  J Transl Int Med       Date:  2020-12-31

8.  A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.

Authors:  Ali Karimi; Marziyeh Abolhasani; Morteza Hashemzadeh-Chaleshtori; Batoul Pourgheysari
Journal:  Indian J Med Res       Date:  2015-07       Impact factor: 2.375

9.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.